Chargement en cours...
Oncogenic drivers, targeted therapies, and acquired resistance in non-small-cell lung cancer
In the past decade, a shift toward targeted therapies in non-small-cell lung cancer following molecular profiling has dramatically changed the way advanced adenocarcinoma is treated. However, tumor cells inevitably acquire resistance to such therapies, circumventing any sustained clinical benefit. A...
Enregistré dans:
| Publié dans: | J Mol Med (Berl) |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2014
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5696571/ https://ncbi.nlm.nih.gov/pubmed/24852181 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00109-014-1165-y |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|